[Molecular biology: generality].
The molecular analysis of chromosomal abnormalities associated with hematologic malignancies allowed the identification of genes involved in these rearrangements as well as of some recurrent mechanisms--gene deregulation, gene fusion--leading to the development of a tumoral process. PCR tools are now available, in addition to conventional and molecular cytogenetics, to detect and quantify these rearrangements, allowing a better follow-up for the patients.